Sotera Health Co (SHC)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $4.74B
Last updated: Nov 17, 2026 at 4:15 PM ET
Sotera Health Co (SHC) Statistics
Sotera Health (SHC) has a market cap of $4.74B and an enterprise value of $6.60B. Its return on invested capital of 8.96% compares with a 2.74% median across 7 similar companies.
Total Valuation
Enterprise value is 39.21% above the market cap, as debt exceeds cash.
| Market Cap | $4.74B |
|---|---|
| Enterprise Value | $6.60B |
| Latest price (Nov 17, 2026) | $16.05 |
Key Dates
The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 3, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 3.7x and 6.3x. Its year-end P/E ranged from 8.6x to 227.0x from 2020 to 2025.
| P/E Ratio | 16.9x |
|---|---|
| Forward P/E | 16.2x |
| P/S Ratio | 3.7x |
| Forward P/S | 3.8x |
| P/B Ratio | 6.3x |
| P/FCF Ratio | 33.9x |
| P/OCF Ratio | 14.3x |
| PEG Ratio | 1.6 |
Enterprise Valuation
Counting debt and cash, the company is valued at 11.7x EBITDA and 47.6x free cash flow.
| EV / Earnings | 38.1x |
|---|---|
| EV / Sales | 5.4x |
| EV / EBITDA | 11.7x |
| EV / EBIT | 15.9x |
| EV / FCF | 47.6x |
Price Statistics
The stock is up 2.62% over 52 weeks and trades 10.13% below its 50-day average.
| Beta (1Y) | 0.98 |
|---|---|
| 52-Week Change | +2.62% |
| 1-Month Change | -9.01% |
| 3-Month Change | -15.53% |
| 6-Month Change | +5.38% |
| 5-Year Change | -26.52% |
| Total Return (1Y) | +2.62% |
| Total Return (3Y CAGR) | +5.53% |
| Total Return (5Y CAGR) | -6.60% |
| Return vs SPY (1Y) | -6.17% |
| Max Drawdown (1Y) | -32.14% |
| Max Drawdown (3Y) | -43.48% |
| Sharpe Ratio (1Y) | 0.17 |
| Correlation with SPY (1Y) | 0.45 |
| 50-Day Average | $17.86 |
| 200-Day Average | $16.87 |
| 52-Week Range | $13.09 to $19.85 |
| RSI (14 Days) | 36.4 |
| Average Volume (20 Days) | 2.82M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.13x current liabilities, and total debt is 3.10x shareholder equity.
| Current Ratio | 3.13x |
|---|---|
| Quick Ratio | 2.91x |
| Debt / Equity | 3.10x |
| Debt / EBITDA | 4.13x |
| Debt / FCF | 16.78x |
| Interest Coverage | 208.41x |
Returns and Efficiency
Return on invested capital is 8.96% over the last 12 months, against a 5-year average of 7.76%.
| Return on Equity (ROE) | 23.66% |
|---|---|
| Return on Assets (ROA) | 5.12% |
| Return on Invested Capital (ROIC) | 8.96% |
| Return on Capital Employed (ROCE) | 13.10% |
| ROE (5Y Average) | -10.36% |
| ROA (5Y Average) | -0.47% |
| ROIC (5Y Average) | 7.76% |
| Asset Turnover | 0.37x |
| Inventory Turnover | 10.53x |
| Receivables Turnover | 8.11x |
| Cash Conversion Cycle | 21 days |
Taxes
Income tax took 36.90% of pretax income over the last 12 months.
| Income Tax (TTM) | $101.42M |
|---|---|
| Effective Tax Rate | 36.90% |
Scores
SHC has an Altman Z-Score of 1.81, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.81 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.23B over the last 12 months is up 6.90% from the 12 months before.
| Revenue | $1.23B |
|---|---|
| Revenue Growth (YoY) | +6.90% |
| Gross Profit | $671.74M |
| Operating Income | $466.59M |
| Pretax Income | $274.89M |
| Net Income | $173.47M |
| EBITDA | $549.81M |
| EBIT | $414.44M |
| Reported EPS (TTM) | $0.95 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 21.63% of the $3.39B in total assets.
| Cash and Equivalents | $412.38M |
|---|---|
| Total Debt | $2.27B |
| Net Debt | $1.86B |
| Net Debt Per Share | $6.50 |
| Working Capital | $477.34M |
| Shareholder Equity | $733.24M |
| Book Value Per Share | $2.56 |
| Tangible Book Value | -$622.81M |
| Total Assets | $3.39B |
| Total Liabilities | $2.65B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $196.15M of capital spending, operating cash flow left $135.43M of free cash flow.
| Operating Cash Flow | $331.58M |
|---|---|
| Capital Expenditures | $196.15M |
| Free Cash Flow | $135.43M |
| FCF Per Share | $0.47 |
| Depreciation and Amortization | $135.36M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 37.94%.
| Gross Margin | 54.62% |
|---|---|
| Operating Margin | 37.94% |
| Pretax Margin | 22.35% |
| Net Margin | 14.11% |
| EBITDA Margin | 44.71% |
| EBIT Margin | 33.70% |
| FCF Margin | 11.01% |
Growth
| Revenue Growth (5Y CAGR) | +7.30% |
|---|---|
| EPS Growth (3Y CAGR) | -3.93% |
| EPS Growth (5Y CAGR) | +48.05% |
| FCF Growth (3Y CAGR) | +16.00% |
| FCF Growth (5Y CAGR) | +17.33% |
| Operating Income Growth (3Y CAGR) | +13.39% |
| Book Value Per Share Growth (2Y CAGR) | +16.24% |
Dividends and Yields
SHC does not pay a dividend. Its free cash flow yield is 2.95%.
| Earnings Yield | 5.92% |
|---|---|
| FCF Yield | 2.95% |
| Shareholder Yield | 0.00% |
Peer Position
Against 8 similar companies, SHC has the 8th highest P/E.
P/E RatioPeer median 33.8x
P/S RatioPeer median 4.8x
ROICPeer median 2.74%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +17.18%
| P/E Ratio | 16.9x vs 33.8x median |
|---|---|
| P/S Ratio | 3.7x vs 4.8x median |
| ROIC | 8.96% vs 2.74% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +6.90% vs +17.18% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.19% and EPS growth at 11.28% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.19% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +11.28% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SHC
What is SHC's market cap?
Sotera Health has a market cap of $4.74B. Its enterprise value, which adds debt and subtracts cash, is $6.60B.
What is SHC's P/E ratio?
Sotera Health has a trailing P/E ratio of 16.9x and a forward P/E of 16.2x.
How many shares of SHC are outstanding?
Sotera Health has 286.00M shares outstanding. The count is up 0.68% from a year earlier.
Does SHC pay a dividend?
No. Sotera Health does not pay a dividend.
How much debt does SHC have?
Sotera Health has $2.27B of total debt and $412.38M of cash and equivalents, a net debt position of $1.86B.
SHC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors